Jonathan Fox
Presidente en EIDOS THERAPEUTICS, INC. .
Fortuna: 173 061 $ al 30/04/2024
Cargos activos de Jonathan Fox
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
EIDOS THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/10/2016 | - |
Presidente | 01/10/2016 | - | |
Director/Miembro de la Junta | 01/10/2016 | - | |
Corporate Officer/Principal | 01/10/2016 | - | |
EDGEWISE THERAPEUTICS, INC. | Director/Miembro de la Junta | 02/03/2023 | - |
Independent Dir/Board Member | 02/03/2023 | - | |
BRIDGEBIO PHARMA, INC. | Director Técnico/Científico/I+D | - | - |
Presidente | - | - | |
ML Bio Solutions, Inc. | Director/Miembro de la Junta | - | - |
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Lankenau Institute for Medical Research operates as a non-profit biomedical research centre. It provides human health and well being through technology development and the training to the next generation of scientists and physicians. The company was founded in 1917 and is headquartered Wynnewood, PA. | Director/Miembro de la Junta | - | - |
Historial de carrera de Jonathan Fox
Antiguos cargos conocidos de Jonathan Fox.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MYOKARDIA, INC. | Director Técnico/Científico/I+D | 01/03/2013 | 30/09/2016 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Director Técnico/Científico/I+D | 01/01/2012 | 01/01/2012 |
Stanford University | Corporate Officer/Principal | - | - |
The University of California, San Francisco | Corporate Officer/Principal | - | - |
░░░░░░░░░░ ░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formación de Jonathan Fox.
The University of Chicago | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 14 |
Operativa
Corporate Officer/Principal | 6 |
Chief Tech/Sci/R&D Officer | 4 |
Director/Board Member | 4 |
Sectorial
Health Technology | 9 |
Consumer Services | 5 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
EDGEWISE THERAPEUTICS, INC. | Health Technology |
BRIDGEBIO PHARMA, INC. | Health Technology |
Empresas privadas | 6 |
---|---|
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Eidos Therapeutics, Inc.
Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
ML Bio Solutions, Inc. | |
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Lankenau Institute for Medical Research operates as a non-profit biomedical research centre. It provides human health and well being through technology development and the training to the next generation of scientists and physicians. The company was founded in 1917 and is headquartered Wynnewood, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Jonathan Fox
- Experiencia